rs146976547

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BS1_SupportingBS2

The NM_015426.5(POC1A):​c.784C>T​(p.Arg262Trp) variant causes a missense change. The variant allele was found at a frequency of 0.000216 in 1,614,032 control chromosomes in the GnomAD database, including 6 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R262Q) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00024 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 5 hom. )

Consequence

POC1A
NM_015426.5 missense

Scores

5
8
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:1

Conservation

PhyloP100: 3.90

Publications

3 publications found
Variant links:
Genes affected
POC1A (HGNC:24488): (POC1 centriolar protein A) POC1 proteins contain an N-terminal WD40 domain and a C-terminal coiled coil domain and are part of centrosomes. They play an important role in basal body and cilia formation. This gene encodes one of the two POC1 proteins found in humans. Mutations in this gene result in short stature, onychodysplasia, facial dysmorphism, and hypotrichosis (SOFT) syndrome. [provided by RefSeq, Sep 2012]
POC1A Gene-Disease associations (from GenCC):
  • short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BS1
Variant frequency is greater than expected in population mid. GnomAdExome4 allele frequency = 0.000213 (312/1461874) while in subpopulation MID AF = 0.012 (69/5768). AF 95% confidence interval is 0.0097. There are 5 homozygotes in GnomAdExome4. There are 171 alleles in the male GnomAdExome4 subpopulation. Median coverage is 31. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POC1ANM_015426.5 linkc.784C>T p.Arg262Trp missense_variant Exon 7 of 11 ENST00000296484.7 NP_056241.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POC1AENST00000296484.7 linkc.784C>T p.Arg262Trp missense_variant Exon 7 of 11 1 NM_015426.5 ENSP00000296484.2
POC1AENST00000394970.6 linkc.784C>T p.Arg262Trp missense_variant Exon 7 of 10 1 ENSP00000378421.2
POC1AENST00000474012.1 linkc.670C>T p.Arg224Trp missense_variant Exon 7 of 11 2 ENSP00000418968.1

Frequencies

GnomAD3 genomes
AF:
0.000243
AC:
37
AN:
152040
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000725
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000655
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000415
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000353
Gnomad OTH
AF:
0.000959
GnomAD2 exomes
AF:
0.000243
AC:
61
AN:
251358
AF XY:
0.000280
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000260
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000139
Gnomad NFE exome
AF:
0.000334
Gnomad OTH exome
AF:
0.000653
GnomAD4 exome
AF:
0.000213
AC:
312
AN:
1461874
Hom.:
5
Cov.:
31
AF XY:
0.000235
AC XY:
171
AN XY:
727242
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000224
AC:
10
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000417
AC:
36
AN:
86258
European-Finnish (FIN)
AF:
0.000187
AC:
10
AN:
53420
Middle Eastern (MID)
AF:
0.0120
AC:
69
AN:
5768
European-Non Finnish (NFE)
AF:
0.000141
AC:
157
AN:
1111992
Other (OTH)
AF:
0.000397
AC:
24
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
19
38
56
75
94
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000243
AC:
37
AN:
152158
Hom.:
1
Cov.:
32
AF XY:
0.000269
AC XY:
20
AN XY:
74388
show subpopulations
African (AFR)
AF:
0.0000723
AC:
3
AN:
41506
American (AMR)
AF:
0.0000654
AC:
1
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.000415
AC:
2
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10614
Middle Eastern (MID)
AF:
0.0170
AC:
5
AN:
294
European-Non Finnish (NFE)
AF:
0.000353
AC:
24
AN:
67980
Other (OTH)
AF:
0.000949
AC:
2
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
6
9
12
15
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000413
Hom.:
0
Bravo
AF:
0.000283
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.000222
AC:
27
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.000600
EpiControl
AF:
0.000533

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:6Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:2
Oct 17, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 262 of the POC1A protein (p.Arg262Trp). This variant is present in population databases (rs146976547, gnomAD 0.03%). This variant has not been reported in the literature in individuals affected with POC1A-related conditions. ClinVar contains an entry for this variant (Variation ID: 211926). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt POC1A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -

May 02, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome Uncertain:2
May 05, 2020
Baylor Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. -

Aug 09, 2021
Department of Pathology and Laboratory Medicine, Sinai Health System
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:research

- -

not specified Uncertain:1Benign:1
-
Pathology and Clinical Laboratory Medicine, King Fahad Medical City
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 06, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Uncertain:1
Aug 02, 2021
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.784C>T (p.R262W) alteration is located in exon 7 (coding exon 7) of the POC1A gene. This alteration results from a C to T substitution at nucleotide position 784, causing the arginine (R) at amino acid position 262 to be replaced by a tryptophan (W). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.46
BayesDel_addAF
Benign
-0.15
T
BayesDel_noAF
Benign
-0.15
CADD
Pathogenic
34
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.18
T;.;.
Eigen
Uncertain
0.56
Eigen_PC
Uncertain
0.48
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Pathogenic
1.0
D;D;D
M_CAP
Benign
0.039
D
MetaRNN
Uncertain
0.70
D;D;D
MetaSVM
Benign
-0.33
T
MutationAssessor
Uncertain
2.7
M;M;.
PhyloP100
3.9
PrimateAI
Uncertain
0.64
T
PROVEAN
Pathogenic
-6.9
D;D;D
REVEL
Uncertain
0.36
Sift
Pathogenic
0.0
D;D;D
Sift4G
Pathogenic
0.0010
D;D;D
Polyphen
1.0
D;D;.
Vest4
0.68
MVP
0.76
MPC
1.1
ClinPred
0.54
D
GERP RS
2.8
Varity_R
0.74
gMVP
0.55
Mutation Taster
=47/53
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs146976547; hg19: chr3-52172214; COSMIC: COSV56592479; API